Recruitment

Recruitment Status
Completed

Inclusion Criteria

treated with oral agents in monotherapy or combined therapy ± basal insulin
has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use
treated with oral agents in monotherapy or combined therapy ± basal insulin
has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use

Exclusion Criteria

pregnancy
has type 2 diabetes non-pharmacologically treated
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
...
pregnancy
has type 2 diabetes non-pharmacologically treated
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
has type 2 diabetes treated with multiple daily injections of insulin
is unable to use the telemedicine system

Summary

Conditions
Type 2 Diabetes Mellitus
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)

Participation Requirements

Age
Between 45 years and 125 years
Gender
Both males and females

Inclusion Criteria

treated with oral agents in monotherapy or combined therapy ± basal insulin
has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use
treated with oral agents in monotherapy or combined therapy ± basal insulin
has type 2 diabetes
previously educated to self-monitoring blood glucose (SMBG) use

Exclusion Criteria

pregnancy
has type 2 diabetes non-pharmacologically treated
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
...
pregnancy
has type 2 diabetes non-pharmacologically treated
has any disease or condition, including alcohol or drugs abuse, that may interfere with study completion
has major cardiovascular, cerebrovascular, or peripheral vascular event in the last 6 months
has type 2 diabetes treated with multiple daily injections of insulin
is unable to use the telemedicine system

Tracking Information

NCT #
NCT02194608
Collaborators
Not Provided
Investigators
Not Provided